Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients

BACKGROUND: Effective therapies to combat coronavirus 2019 (COVID-19) are urgently needed. Hydroxychloroquine (HCQ) has in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the clinical benefit of HCQ in treating COVID-19 is unclear. Randomized contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulrich, Robert J, Troxel, Andrea B, Carmody, Ellie, Eapen, Jaishvi, Bäcker, Martin, DeHovitz, Jack A, Prasad, Prithiv J, Li, Yi, Delgado, Camila, Jrada, Morris, Robbins, Gabriel A, Henderson, Brooklyn, Hrycko, Alexander, Delpachitra, Dinuli, Raabe, Vanessa, Austrian, Jonathan S, Dubrovskaya, Yanina, Mulligan, Mark J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543602/
https://www.ncbi.nlm.nih.gov/pubmed/33134417
http://dx.doi.org/10.1093/ofid/ofaa446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543602/
https://www.ncbi.nlm.nih.gov/pubmed/33134417
http://dx.doi.org/10.1093/ofid/ofaa446

Ejemplares similares